Amundi’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-23
Closed -$461 1817
2025
Q1
$461 Hold
23
﹤0.01% 2124
2024
Q4
$555 Buy
+23
New +$555 ﹤0.01% 2094